Home >Research Technology Management>Technology for Licensing

Assays & Technologies

Hepatitis Research Laboratory

HBV epsilon Polymerase assay [Code No: IPK0201]

This cell-based assay using 384-well plates is used to evaluate viral polymerase interaction with pregenomic RNA encapsidation signal epsilon.

HBV polymerase interferon β reporter assay [Code No: IPK0202]

This cell-based assay using 384-well plates is used to evaluate HBV polymerase interference with type I interferon signaling.

HBV nucleocapsid-captured quantitative real-time RT-PCR assay [Code No: IPK0203]

This cell-based assay using 384-well plates is used to evaluate intracellular encpasidated pgRNA.

HBVcc infection assay [Code No: IPK0204]

This cell-based assay using 384-well plates is used to evaluate early steps (entry, decapsidation, ccDNA synthesis, etc.) in the viral life cycle.

HBV replication assay [Code No: IPK0205]

This cell-based assay using 96-well plates is used to evaluate HBV DNA replication (intra-, extra-cellular viral genomes).

HBV drug combination assay [Code No: IPK0206]

This cell-based assay using 96-well plates is used to evaluate HBV replication in the presence of two inhibitors.

HCVcc infection assay [Code No: IPK0207]

This cell-based assay using 384-well plates is used to evaluate all steps in the viral life cycle.

HCV RNA replication assay in replicon system [Code No: IPK0208]

This cell-based assay using 384-well plates is used to evaluate HCV RNA replication.

HCV pseudoparticle entry assay [Code No: IPK0209]

This cell-based assay using 384-well plates is used to evaluate HCV E1/E2-mediated entry.

HCV protease assay [Code No: IPK0210]

This in vitro assay using 384-well plates is used to evaluate NS3 protease activity.

HCV helicase assay [Code No: IPK0211]

This in vitro assay using 384-well plates is used to evaluate NS3 helicase activity.

HCV polymerase assay [Code No: IPK0212]

This in vitro assay using 384-well plates is used to evaluate NS5B polymerase activity.

HCV spread assay [Code No: IPK0213]

It is a cell-based assay using 96-well plate to evaluate HCV cell-to-cell spread.

HCV entry kinetics assay [Code No: IPK0214]

This cell-based assay using 384-well plates is used to evaluate HCV entry steps in detail (binding, post entry).

HCV equilibrium density gradient [Code No: IPK0215]

This cell-based assay using a 10 cm dish is used to evaluate intra- and extracellular HCV particle formation.

HCV drug combination assay [Code No: IPK0216]

This cell-based assay using 384-well plates is used to evaluate HCV replication in the presence of two inhibitors.

HCV virucidal assay [Code No: IPK0217]

This in vitro assay is used to evaluate virucidal activity of antivirals.